Cardiovasology

描述(由申请人提供)：修改后的申请是申请继续资助31-35年的“心血管学”培训计划。该计划成功地完成了为心血管医学和生物学领域的独立研究生涯培养内科医生和非内科医生科学家的使命。学员在发表高质量的同行评审论文方面表现出色，并在助学金申请和学术安置方面建立了良好的记录。在获奖的每一年，所有的职位都由有才华的医学博士和博士候选人填补。梅奥诊所以人类疾病为中心，为基础、临床和人群心血管科学的培训提供了良好的环境。成就包括强劲的实习生招聘和留住，与优秀教师的互动指导，稳健的组织结构和有利的环境，产生富有成效的学术生涯。在卓越传统的基础上，更新是为了满足最高的教育标准，并提供尖端的博士后培训。课程是根据每个学员的背景和职业道路进行定制的。心力衰竭、缺血性心脏病和心律失常这一疾病主题是培训的重点，反映了各国的发病率和死亡率趋势。修订后的应用程序致力于NHLBI计划的重点，整合了最先进技术的多学科培训，从工作台到床边的全面课程，以实现不断发展的科学需求领域的能力，以及研究生存技能的教学和实践指导。该计划汇集了一个由基础科学家、临床研究人员和人口科学家组成的具有互补专业知识的协作团队。作为对国立卫生研究院研究科建议的回应，重新提交包括一个新的同事到教师的职业发展计划，以促进受训人员更早地过渡到独立教师身份，并实施了一个加强的少数族裔招聘计划，以增加接受培训的少数族裔个人的数量。该计划利用有利的技术平台，以及梅奥诊所的学位授予计划，从而获得硕士/博士学位。获得应用于心脏病研究的基因组学、蛋白质组学、代谢组学和生物信息学方面的技能，对于培训学员为未来的生物医学做准备至关重要。新的服务包括遗传流行病学和医学信息学；药物基因组学；计算生物学；纳米医学；以及基于细胞的疗法。修订后的申请强调了“心血管病学”培训计划的愿景，即提供最先进的培训，吸引和指导内科科学家和基础研究人员，他们将成为心血管研究生物学和医学领域的先锋。

Description (provided by applicant): The revised application is a request for continuation of funding for years 31-35 of the "Cardiovasology" Training Program. This Program has successfully accomplished its mission in preparing physicians and nonphysician scientists for independent research careers in cardiovascular medicine and biology. Trainees have excelled in publishing high quality peer-reviewed papers, and have established a track-record of grant applications and academic placement. All slots were filled, in each of the awarded years, by talented MD and PhD candidates. Mayo Clinic has provided an outstanding environment for training in basic, clinical and population cardiovascular sciences with human disease as the central theme. Accomplishments include strong trainee recruitment and retention, interactive mentoring with outstanding faculty, robust organizational structure, and conducive environment, yielding productive academic careers. Building on a tradition of excellence, the renewal is developed to meet the highest educational standards, and offer cutting-edge postdoctoral training. The curriculum is customized to match the background and career path of each trainee. The disease theme of heart failure, ischemic heart disease and heart rhythm disorders is the focus of training, reflecting national morbidity and mortality trends. Committed to NHLBI programmatic emphases, the revised application integrates multidisciplinary training in state-of-the-art technologies, a comprehensive curriculum to achieve competencies in evolving areas of scientific need from the bench to the bedside, and didactic and practical instruction in research survival skills. The Program brings together a collaborative team of basic scientists, clinical investigators and population scientists with complementary expertise. In response to NIH Study Section recommendations, the resubmission incorporates a new fellow-to-faculty career development program established to foster an earlier transition of trainees into independent faculty status, and an enhanced minority recruitment plan implemented to increase the number of minority individuals who receive training. The Program capitalizes on enabling technological platforms, and degree-granting programs at the Mayo Clinic that lead to master/doctorate degrees. Acquisition of skills in genomics, proteomics, metabolomics and bioinformatics, applied to the study of heart disease, is paramount to preparing trainees for the biomedicine of tomorrow. New offerings include genetic epidemiology and medical informatics; pharmacogenomics; computational biology; nanomedicine; and cell-based therapies. The revised application underscores the vision of the "Cardiovasology" Training Program to provide most advanced training, attracting and mentoring physician-scientists and fundamental investigators who will comprise the vanguard of leadership in the biology and medicine of cardiovascular research.